Vascular Growth Factors in Health and Diseases
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: closed (15 November 2023) | Viewed by 1705
Special Issue Editors
Interests: angiogenesis; signal transduction; cardiovascular diseases
Special Issue Information
Dear Colleagues,
Vascular endothelial growth factors (VEGFs) play a central role in regulating physiological angiogenesis. However, in several pathological conditions, such as in cancer, in cardiovascular diseases and in retinopathy, the physiological and protective role of VEGs could deviate and become deleterious, inducing the increased permeability of the endothelium, decreased inhibition of pro-apoptotic proteins and activation of inflammation. Anti-VEGF therapy strategies have been developed and approved for clinical use in cancer and retinopathy, but at the moment, anti-VEGF treatments require careful patient selection and monitoring. In addition, sometimes they fail to promote appropriate beneficial adaptive responses. The present Special Issue of Cell aims to summarize some of the latest advances in understanding the role of VEGFs in cancer, cardiovascular diseases and retinopathies, focusing on the involved cellular pathways, neuroinflammation and signaling pathways. We also welcome manuscripts that address therapeutic strategies in this field. For this purpose, we are encouraging basic and clinical researchers to present their valuable work as a scientific contribution or review articles. We would appreciate your contribution, and it will be a pleasure for us to receive your manuscripts. Our aim is to provide a comprehensive update on the role of VEGFs in disease and on their therapy options.
Dr. Silvana Balzan
Dr. Rosario Amato
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
